Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zahn

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Virology|October 3, 2008
Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagmRoland C Zahn, Melisa D Rett, Birgit Korioth-Schmitz, et al.
Vaccines|December 23, 2023
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in RabbitsSelina Khan, Sonia Marquez-Martinez, Tim Erkens, et al.
Vaccine|January 2, 2022
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical modelsEirikur Saeland, Leslie van der Fits, Renske Bolder, et al.
NPJ Vaccines|February 24, 2022
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of miceShant H Mahrokhian, Lisa H Tostanoski, Catherine Jacob-Dolan, et al.
Blood|February 12, 2010
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce diseaseRoland C Zahn, Melisa D Rett, Ming Li, et al.
NPJ Vaccines|March 23, 2023
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical modelsEirikur Saeland, Leslie van der Fits, Renske Bolder, et al.
Frontiers in Immunology|October 30, 2018
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in MiceJoan E M van der Lubbe, Johan W A Verspuij, Jeroen Huizingh, et al.
Vaccines|May 25, 2024
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic ThrombocytopeniaSonia Marquez-Martinez, Selina Khan, Joan van der Lubbe, et al.
Nature Communications|April 11, 2024
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbitsAnnemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
NPJ Vaccines|July 7, 2018
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challengeJoan E M van der Lubbe, Jeroen Huizingh, Johan W A Verspuij, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Virology|October 3, 2008
Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagmRoland C Zahn, Melisa D Rett, Birgit Korioth-Schmitz, et al.
Vaccines|December 23, 2023
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in RabbitsSelina Khan, Sonia Marquez-Martinez, Tim Erkens, et al.
Vaccine|January 2, 2022
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical modelsEirikur Saeland, Leslie van der Fits, Renske Bolder, et al.
NPJ Vaccines|February 24, 2022
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of miceShant H Mahrokhian, Lisa H Tostanoski, Catherine Jacob-Dolan, et al.
Blood|February 12, 2010
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce diseaseRoland C Zahn, Melisa D Rett, Ming Li, et al.
NPJ Vaccines|March 23, 2023
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical modelsEirikur Saeland, Leslie van der Fits, Renske Bolder, et al.
Frontiers in Immunology|October 30, 2018
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in MiceJoan E M van der Lubbe, Johan W A Verspuij, Jeroen Huizingh, et al.
Vaccines|May 25, 2024
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic ThrombocytopeniaSonia Marquez-Martinez, Selina Khan, Joan van der Lubbe, et al.
Nature Communications|April 11, 2024
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbitsAnnemart Koornneef, Kanika Vanshylla, Gijs Hardenberg, et al.
NPJ Vaccines|July 7, 2018
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challengeJoan E M van der Lubbe, Jeroen Huizingh, Johan W A Verspuij, et al.
Pageof 7